Stay up to date

News

see all news

New Spanish clinical data from Proclarix® together with Magnetic Resonance Imaging (MRI) for improved prostate cancer diagnosis will be presented at the 36th Annual European Urology Congress.

July 6, 2021

University of Naples Federico II is implementing and evaluating Proclarix® to make it available in Italy

May 4, 2021

Publications

see all publications

Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer.

Klocker H, Golding B, Weber S, Steiner E, Tennstedt P, Keller T, Schiess R, Gillessen S, Horninger W, Steuber T. BJUI Compass. 2020;1:15–20.

Neuer diagnostischer Prozess des Prostatakarzinoms

Engeler D, Korte W, Schiess R. Pipette - Swiss Laboratory Medicine 2020;3:24-26

Events

see all events

Postponed to Dec 13th-17th, 2020 - 2020 AACC Annual Scientific Meeting & Clinical Lab Expo

Chicago, US

Sep 23rd-26th, 2020 - Jahreskongress der Deutschen Gesellschaft für Urologie e.V.

Leipzig, DE

Resources

see all resources

Application note - Implementation of Proclarix in the workflow of a clinical laboratory

Analytical validation of the Proclarix Risk Score for the diagnosis of prostate cancer

Analytical performance of automated thrombospondin-1 and cathepsin D immunoassays for prostate cancer risk assessment